Palonosetron Hydrochloride
Product Images NDC 0781-3415

5 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 0781-3415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Palonosetron Nova 01

Palonosetron Nova 01
Chemical structure of Palonosetron Hydrochloride showing its molecular arrangement including the characteristic bicyclic and piperidine rings with a hydrochloride component.*
FDA Label Image

Palonosetron Nova 02

Palonosetron Nova 02
A vertical bar chart depicting differences in complete response rates, with percentage ranges indicated at three levels: 2% to 23%, -2% to 22%, and -9% to 13%. The x-axis represents difference values from -10 to 35, illustrating response rate variation.*
FDA Label Image

Palonosetron Nova 03

Palonosetron Nova 03
A chart displaying difference in complete response rates with two brackets indicating ranges: one from about 9% to 30%, and another from about 3% to 27%. The horizontal axis is labeled with values from -10 to 35, representing the difference in complete response rates.*
FDA Label Image

Palonosetron Nova 04

Palonosetron Nova 04
A chart depicting differences in complete response rates, with two data ranges indicated: 0% to 24% and 7% to 31%, plotted along a horizontal axis labeled 'Difference in Complete Response Rates' ranging approximately from -10 to 35.*
FDA Label Image

Palonosetron Nova 05

Palonosetron Nova 05
Packaging label for Palonosetron HCl Injection, 0.25 mg/5 mL strength, in a 5 mL single-dose vial by Sandoz Inc. The label indicates the product is for intravenous injection only and is sterile. It includes warnings to discard unused portions and storage instructions, along with the NDC 0781-3415-75 and the Novaplus branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.